January 22, 2020
TARGOVAX ASA – KEY INFORMATION RELATED TO THE SUBSEQUENT OFFERING
Media
January 22, 2020
TARGOVAX ASA – SUCCESSFULLY COMPLETED PRIVATE PLACEMENT
January 21, 2020
Targovax announces encouraging data in mesothelioma study combining ONCOS-102 and standard of care chemotherapy
January 21, 2020
GenSight Biologics Reports its Cash Position as of December 31, 2019 and Provides Operational Update
January 20, 2020
Invitation to presentation of the Full Year Report 2019, incl. Q4, on January 30
January 14, 2020
Fusion Pharmaceuticals Announces Investment From Canada Pension Plan Investment Board (CPPIB)
January 13, 2020
Fusion Pharmaceuticals To Present At The 38th Annual J.P. Morgan Healthcare Conference
January 09, 2020
Aprea Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2020
January 09, 2020
Strongbridge Biopharma plc Announces Preliminary Fourth Quarter and Full-Year 2019 Financial Results and Provides Update on Corporate Priorities
January 08, 2020
Targovax and IOVaxis Therapeutics enters Option Agreement for TG mutant RAS vaccine license and clinical development in China